吉林切割包皮要多少钱啊吉林医院右睾丸有点肿是什么,吉林一次包皮包茎一般多少钱,吉林割包皮去哪里医院比较好,吉林哪家医院治疗阳痿技术好,吉林前列腺钙化影响性功能吗,吉林龟头上有小红点是什么病,吉林前列腺肥大的症状与治疗

HONOLULU, United States, Nov. 10 (Xinhua) -- Chinese President Hu Jintao arrived in Honolulu, Hawaii, on Thursday for the Economic Leaders Meeting of the Asia-Pacific Economic Cooperation (APEC), slated for Saturday and Sunday.At the annual meeting, leaders of the 21-member group will exchange views on economic growth in the Asia-Pacific region, strengthening regional economic integration and expanding trade.They will also consider the promotion of green growth and fostering job creation in green industries, energy security, and expanding regulatory cooperation and advancing regulatory convergence.Chinese President Hu Jintao (C) arrives in Honolulu, Hawaii, U.S., Nov. 10, 2011. Chinese President Hu Jintao arrived in Honolulu, Hawaii, on Thursday for the Economic Leaders Meeting of the Asia-Pacific Economic Cooperation (APEC), slated for Saturday and Sunday.President Hu is expected to speak at the meeting and express his views on the world economic situation and the regional economic situation, Wu Hailong, assistant foreign minister of China, said at a press briefing earlier this week.In his speech, Wu said, the Chinese leader will call for "improving global economic governance, shifting the growth method, promoting economic globalization and regional economic integration."Hu will also explain "China's stand on the issues of free and open trade and investment, green growth, the adjustment of economic structure and regulatory cooperation," Wu said.In Hawaii, Hu will join other APEC leaders in dialogue with the APEC Business Advisory Council (ABAC).APEC leaders are expected to discuss with ABAC representatives, among other things, regional economic integration, reform of the international monetary system, and food security.The Chinese leader is scheduled to deliver a speech at the APEC CEO summit Saturday.On the sidelines of the APEC Economic Leaders Meeting, President Hu will meet U.S. President Barack Obama and other leaders of APEC members."China hopes the meeting will further promote the free and open trade and investment in the Asia-Pacific region, push forward economic and technology cooperation, support multilateral trade systems, oppose trade protectionism, so as to inject vitality into world economic recovery and growth," Assistant Commerce Minister Yu Jianhua said at a press briefing earlier this week.APEC is the premier economic forum in the Asia-Pacific region.Since APEC's birth in 1989 it has grown to encompass 21 members spanning four continents, and represents the most economically dynamic region in the world, accounting for approximately 40 percent of the world's population, around 50 percent of world GDP and about 44 percent of world trade.APEC's 21 member economies are Australia, Brunei, Canada, Chile, China, China's Hong Kong, Indonesia, Japan, Republic of Korea, Malaysia, Mexico, New Zealand, Papua New Guinea, Peru, the Philippines, Russia, Singapore, Chinese Taipei, Thailand, the United States and Vietnam.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.

WASHINGTON, Nov. 14 (Xinhua) -- Vitamin D levels are significantly lower in patients with recurrent inflammatory spinal cord disease, according to a study published online Monday in Archives of Neurology.Vitamin D is a steroid vitamin that promotes the intestinal absorption and metabolism of calcium and phosphorus. In recent years, low levels of vitamin D have been linked to a variety of autoimmune conditions, including multiple sclerosis (MS). However, the importance of vitamin D in monophasic or recurrent non-MS spinal cord diseases including transverse myelitis and neuromyelitis optica is unknown, according to background information in the article.Transverse myelitis (TM) is a disease of the spinal cord in which there is involvement of the myelin sheath that protects nerve fibers; symptoms include back pain and weakness in the legs. Neuromyelitis optica (NMO) is a disease of the central nervous system that affects the optic nerves and spinal cord.Maureen Mealy, of Johns Hopkins University and colleagues investigated the association between low serum vitamin D levels and recurrent spinal cord disease. They analyzed data on vitamin D levels among 77 patients with monophasic (having only one phase or stage) and recurrent inflammatory diseases of the spinal cord, adjusting for season, age, sex, and race. The study found that vitamin D levels were significantly lower in patients who developed recurrent spinal cord disease."Our findings suggest that there may be an association between lower total 25-hydroxyvitamin D levels in patients with recurrent TM/NMO/ spectrum disorders as compared with their counterparts with monophasic disease," the authors report. They suggest that future studies are needed to further assess the relationship between vitamin D and recurrent spinal cord disease.

WASHINGTON, Jan. 1 (Xinhua) -- Twin U.S. spacecraft to study the moon from crust to core put themselves into the lunar orbit on New Year's Eve and New Year's Day, the country's space agency said.The second Gravity Recovery And Interior Laboratory, or GRAIL-B, reached its lunar orbit at 5:43 p.m. EST (2243 GMT) on Sunday, according to the National Aeronautics and Space Administration (NASA).The GRAIL-A started orbiting the moon at 5 p.m. (2200 GMT) Saturday.The insertion maneuvers placed the spacecraft into a near-polar, elliptical orbit with an orbital period of approximately 11.5 hours, NASA said.Over the coming weeks, the GRAIL team will execute a series of burns with each spacecraft to reduce their orbital period to just under two hours. At the start of the science phase in March 2012, the twin GRAILs will be in a near-polar, near-circular orbit with an altitude of about 55 km."NASA greets the new year with a new mission of exploration," Administrator Charles Bolden said in a statement. "The twin GRAIL spacecraft will vastly expand our knowledge of our moon and the evolution of our own planet."During GRAIL's science mission, the two probes will transmit radio signals precisely defining the distance between them. As they fly over areas of greater and lesser gravity caused by visible features such as mountains, craters and masses hidden beneath the lunar surface, the distance between the twin spacecraft will change slightly.Scientists will translate this information into a high-resolution map of the moon's gravitational field.The data will allow scientists to understand what goes on below the lunar surface and increase knowledge of how Earth and its rocky neighbors in the inner solar system developed into the diverse worlds we see today.

HONG KONG, Oct. 13 (Xinhua) -- Computer and electronic device maker Lenovo, listed in both Hong Kong and New York, has replaced Dell to become the world's second largest personal computer company, Lenovo said Thursday.Lenovo made the remarks in a statement, citing figures released by International Data Corporation (IDC), a global provider of business intelligence for the consumer technology market.Following five quarters as the fastest-growing PC maker among the world's top vendors, the preliminary IDC data reported that Lenovo has achieved record market share of around 13.7 percent and record quarterly shipment volume of some 12.6 million units.Lenovo CEO Yang Yuanqing said his company had surpassed two competitors to capture the No. 2 spot in worldwide PCs in just two quarters and it was the highest rank that Lenovo has achieved in worldwide PC sales.Given current competitive environment, the new achievement positioned Lenovo as a strong challenger to ultimately become the global market leader, Yang said in the statement."We are growing in the enterprise and the consumer space. And our customers know we are fully committed to the PC market for the long term," he said.At the same time, the Chinese multinational would continue investing in innovative products that would help drive the convergence of technologies and services across all four screens -- smart phones, tablets, PCs and smart TV, Yang said."We must deliver a great user experience across all platforms to achieve our goal and become the leading personal technology company in the world."Lenovo is a personal technology company and a global Fortune 500 company with annual sales worth 21 billion U.S. dollars. It serves customers in more than 160 countries and regions.